Will Dillard's (DDS) Beat Estimates Again in Its Next Earnings Report? — Positive

DDS   Zacks Investment Research — August 01, 2025

Dillard's (DDS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Dillard's (DDS) Beat Estimates Again in Its Next Earnings Report?

Why Bilibili (BILI) Could Beat Earnings Estimates Again — Positive

BILI   Zacks Investment Research — August 01, 2025

Bilibili (BILI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Why Bilibili (BILI) Could Beat Earnings Estimates Again

Will Five Below (FIVE) Beat Estimates Again in Its Next Earnings Report? — Positive

FIVE   Zacks Investment Research — August 01, 2025

Five Below (FIVE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

image for news Will Five Below (FIVE) Beat Estimates Again in Its Next Earnings Report?

SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- On July 16, 2025, Sarepta Therapeutics (NASDAQ: SRPT) announced a major restructuring that involves, in part, a 36% workforce reduction (500 employees) and other steps to annually save about $400 million. The company also agreed with the FDA to include a black box warning of acute liver injury and acute liver failure in Sarepta's ELEVIDYS label. ELEVIDYS is the company's gene therapy drug intended to treat a limited category of people with Duchenne muscular dystrophy.

image for news Sarepta Therapeutics (SRPT) Announces Restructuring and ELEVIDYS Black Box Warning, EMA Recommends Refusal of Marketing Authorization, Securities Class Action Pending – Hagens Berman

Trade tracker: Bill Baruch buys Thermo Fisher — Positive

TMO   CNBC Television — August 01, 2025

Bill Baruch, founder and president at Blue Line Capital, joins CNBC's “Halftime Report” to explain why he's buying Thermo Fisher here.

image for news Trade tracker: Bill Baruch buys Thermo Fisher

SAN FRANCISCO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- On June 10, 2025, investors in The J.M. Smucker Company (NYSE: SJM) saw the price of their shares decline over 15% after the company announced disappointing Q4 2025 financial results.

image for news The J.M. Smucker Company (SJM) Faces Investor Scrutiny After Announcing The Second Hostess-Related Impairments In About 3 Months – Hagens Berman

MITCHEL FIELD, N.Y., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. (“FEI” or the “Company”) (NASDAQ-FEIM), a leading provider of precision timing and frequency control products, today announced it will host the 2025 Quantum Sensing Summit on October 29–30, 2025, in New York City.

image for news Frequency Electronics Announces 2025 Quantum Sensing Summit in New York City

CoStar files lawsuit against Zillow claiming systematic copyright infringement of photographs distributed across Zillow's network. Many of the images have the CoStar watermark.

image for news Zillow hit with federal copyright lawsuit over 47K allegedly stolen property photos

The Big 3: CHWY, FSLR, NNE — Neutral

CHWY  FSLR   Schwab Network — August 01, 2025

Scott Bauer (@ProsperTradingAcademy) joins Trading 360 with a trio of August expiry example options trades. First, he focuses on Chewy (CHWY) highlighting technical support around the stock's 200-day moving average.

image for news The Big 3: CHWY, FSLR, NNE

AB InBev Q2 Earnings Beat Estimates, Revenues Miss on Soft Volumes — Positive

BUD   Zacks Investment Research — August 01, 2025

BUD beats Q2 EPS estimates on cost discipline and brand strength, but revenues miss amid soft China & Brazil volumes.

image for news AB InBev Q2 Earnings Beat Estimates, Revenues Miss on Soft Volumes

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down — Neutral

CORT   Zacks Investment Research — August 01, 2025

Corcept beats second-quarter earnings forecasts but misses the same for revenues. The company trims its 2025 revenue outlook.

image for news CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down

IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript — Neutral

IRMD   Seeking Alpha — August 01, 2025

IRADIMED CORPORATION (NASDAQ:IRMD ) Q2 2025 Earnings Conference Call August 1, 2025 11:00 AM ET Company Participants John F. Glenn - CFO & Corporate Secretary Roger E.

image for news IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript

The U.S. Food and Drug Administration approved on Friday, the Novo Nordisk A/S NVO Alhemo (concizumab-mtci) injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years of age and older with hemophilia A or B without inhibitors.

image for news Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients

Custom Truck One Source, Inc. (NYSE:CTOS ) Q2 2025 Earnings Call July 31, 2025 9:00 AM ET Company Participants Brian Perman - Vice President of Investor Relations Christopher J. Eperjesy - Chief Financial Officer Ryan McMonagle - CEO & Director Conference Call Participants Naim Gavriel Kaplan - Deutsche Bank AG, Research Division Operator Hello, and welcome to the Custom Truck One Source Inc. Second Quarter 2025 Earnings Conference Call.

image for news Custom Truck One Source, Inc. (CTOS) Q2 2025 Earnings Conference Call Transcript

Franklin Resources, Inc. (BEN) Q3 2025 Earnings Call Transcript — Neutral

BEN   Seeking Alpha — August 01, 2025

Franklin Resources, Inc. (NYSE:BEN ) Q3 2025 Earnings Conference Call August 1, 2025 10:00 AM ET Company Participants Adam Benjamin Spector - Executive VP & Head of Global Distribution Jennifer M. Johnson - President, CEO & Director Matthew Nicholls - Executive VP, CFO & COO Selene Oh - Head of Investor Relations Conference Call Participants Alexander Blostein - Goldman Sachs Group, Inc., Research Division Brian Bertram Bedell - Deutsche Bank AG, Research Division Daniel Thomas Fannon - Jefferies LLC, Research Division Glenn Paul Schorr - Evercore ISI Institutional Equities, Research Division Kenneth Brooks Worthington - JPMorgan Chase & Co, Research …

image for news Franklin Resources, Inc. (BEN) Q3 2025 Earnings Call Transcript

CRM vs. NOW: Which Workflow Automation Stock Has More Upside? — Positive

CRM  NOW   Zacks Investment Research — August 01, 2025

ServiceNow NOW and Salesforce CRM are leading workflow automation platforms, helping enterprises streamline operations through cloud-based software and AI-powered tools. Platforms provided by these companies are widely used by large enterprises to drive efficiency and improve service delivery.

image for news CRM vs. NOW: Which Workflow Automation Stock Has More Upside?

What Makes Tenable (TENB) a New Buy Stock — Positive

TENB   Zacks Investment Research — August 01, 2025

Tenable (TENB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news What Makes Tenable (TENB) a New Buy Stock

Evercore (EVR) Is Up 0.86% in One Week: What You Should Know — Positive

EVR   Zacks Investment Research — August 01, 2025

Does Evercore (EVR) have what it takes to be a top stock pick for momentum investors? Let's find out.

image for news Evercore (EVR) Is Up 0.86% in One Week: What You Should Know

Coupang (CPNG) Upgraded to Buy: Here's What You Should Know — Positive

CPNG   Zacks Investment Research — August 01, 2025

Coupang (CPNG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

image for news Coupang (CPNG) Upgraded to Buy: Here's What You Should Know

Metalla Royalty & Streaming Ltd. (MTA) is a Great Momentum Stock: Should You Buy? — Positive

MTA   Zacks Investment Research — August 01, 2025

Does Metalla Royalty & Streaming Ltd. (MTA) have what it takes to be a top stock pick for momentum investors?

image for news Metalla Royalty & Streaming Ltd. (MTA) is a Great Momentum Stock: Should You Buy?